IPhepase ds820a

Sharraxaadda Gaaban:

DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

Si faahfaafo

Calaamadaha wax soo saarka

  • Dhex qori Ds Waxay isku daraysaa iyada HER2 - Bartilmaameedsiga monoclonal-ka monoclonal (oo la mid ah trastuzumab) oo leh todotent Topoisomerase inoopomerase Waan xakameeyaa (deruxxtcan) sida mushaharka cytotoxc. Daroogada ayaa si toos ah u soo bandhiga kemotherapy-ga Cheotherapy-ga oo muujinaya Her2, hagaajinta waxtarka iyadoo la xayirayo waxyeelada unugyada caadiga ah.
    • Qeybta:
      Keniisaddaa
    • Shayga no.:
      015200.02
    • Cabbirka Unugga:
      200l, 2mg / ml
    • Unugyada:
      N / a
    • Noocyada:
      N / a
    • Xaaladaha kaydinta iyo gaadiidka:
      Kaydso AT - 70 ° C. Baraf qalalan ayaa la keenay.

  • Hore:
  • Xiga:
  • Xulashada Luqadda